462 JOURNAL OF CHEMICAL RESEARCH 2013
115.8 (d, JF-C = 22.5 Hz), 143.5 (d, JF-C = 1.9 Hz), 156.2 (d, JF-C
234.2 Hz), 171.1.
=
cm−1; 1H NMR (CDCl3): δ 1.18 (t, J = 7.2 Hz, 3H, CH2CH3), 1.82 (s,
3H, CH3C=O), 4.08 (s, 2H, AcNCH2), 4.11 (q, J = 7.2 Hz, 2H,
CH2CH3), 4.30 (s, 2H, CH2COO), 7.23–7.27 (m, 1H, ArH), 7.26–7.36
(m, 8H, ArH); 13C NMR (CDCl3): δ 14.1, 22.0, 51.3, 51.7, 61.3, 127.9,
128.0, 129.5, 129.7, 130.1, 134.5, 140.1, 143.6, 168.3, 168.7, 170.6;
HRMS-ESI (positive) calcd for C20H21ClN2NaO4+ [M + Na]+:
411.1082; found: 411.1081; Eluent: PE/acetone (2/1, v/v), Rf = 0.44.
Ethyl 2-(N-(2-chlorophenyl)-2-(N-phenylacetamido)acetamido)-
acetate (3f): Pale yellow oil(59%), IR: 1751 (C=O), 1690 (C=O),
1662 (C=O) cm−1; 1H NMR (CDCl3): δ 1.28 (t, J = 7.2 Hz, 3H,
OCH2CH3), 1.92 (s, 3H, CH3C=O), 3.70 (d, J = 17.4 Hz, 1H, one
proton of CH2COO), 3.99 (d, J = 16.4 Hz, 1H, one proton ofAcNCH2),
4.16–4.24 (m, 2H, CH2CH3), 4.26 (d, J = 16.4 Hz, 1H, another proton
of AcNCH2), 5.04 (d, J = 17.4 Hz, 1H, another proton of CH2COO),
7.32–7.42 (m, 7H, ArH), 7.49–7.53 (m, 1H, ArH), 7.70–7.74 (m,
1H, ArH); 13C NMR (CDCl3): δ 14.1, 22.1, 49.9, 51.4, 61.2, 127.9
(overlap, 2C), 128.2, 129.5, 130.3, 130.6, 131.6, 132.9, 138.4, 143.5,
168.4, 168.6, 170.6; HRMS-ESI (positive) calcd for C20H21ClN2NaO4+
[M + Na]+: 411.1082; found: 411.1079; Eluent: PE/acetone (2/1, v/v),
Rf = 0.37.
Ethyl 2-((4-bromophenyl)amino)acetate (1i): Colourless flakes
(69%), m.p. 95–96 °C (lit.25 94–95 °C) (EtOH), IR: 3376 (NH), 1721
1
(C=O) cm−1; H NMR (CDCl3): δ 1.32 (t, J = 7.2 Hz, 3H, CH2CH3),
3.87 (d, J = 5.6 Hz, 2H, NCH2), 4.26 (q, J = 7.2 Hz, 2H, CH2CH3),
4.36 (t, J = 5.6 Hz, 1H, NH), 6.50 (d, J = 8.8 Hz, 2H, ArH), 7.29 (d,
J = 8.8 Hz, 2H, ArH); 13C NMR (CDCl3): δ 14.2, 45.7, 61.5, 109.9,
114.5, 132.0, 146.0, 170.8.
3-(1,3-Dioxoisoindolin-2-yl)propanoic acid (2e): A mixture of
β-alanine (5.0 g, 0.056 mol), phthalic anhydride (8.7 g, 0.059 mol),
and DMF (20 mL) was refluxed under stirring for 3 h. The resulting
mixture was cooled to room temperature, poured into ice-water
(~100 mL), and then filtered by suction. The filter cake was sequen-
tially washed with water (15 mL × 3), alcohol (3 mL × 3), and ether
(10 mL × 2), and then dried in vacuo to give 2e (9.9 g, 80%) as a white
solid, m.p. 148–150 °C (lit.26 152 °C), IR: 1773 (C=O), 1699 (C=O)
cm−1; 1H NMR (DMSO-d6): δ 2.61 (t, J = 7.2 Hz, 2H, CH2COO), 3.79
(t, J = 7.2 Hz, 2H, NCH2), 7.82–7.89 (m, 4H, ArH), 12.40 (brs, 1 H,
COOH).
Ethyl 2-(N-(3-chlorophenyl)-2-(N-phenylacetamido)acetamido)-
Direct amide formation catalysed by PhB(OH)2; typical procedure
PhB(OH)2 (6 mg, 0.05 mmol), and xylene (10 mL) were added to a
round-bottom flask (100 mL), 1a (90 mg, 0.5 mmol), 2a (97 mg,
0.5 mmol). A pressure equalising dropping funnel, in which 4 Å
molecular sieves (6 g) were placed, was installed onto the flask. Then
a condenser was connected to the dropping funnel. After refluxing
under stirring for 10 h, the reaction mixture was cooled down to room
temperature, and evaporated to remove solvent. The resulting residue
was dissolved in EtOAc (20 mL), and then sequentially washed with
0.1 M NaOH (20 mL), water (20 mL), and brine (20 mL). The organic
layer was dried over anhydrous MgSO4, filtered, and concentrated
under reduced pressure. The resulting residue was subjected to
preparative TLC (eluted with PE/acetone (2/1, v/v), Rf = 0.43) to
afford ethyl 2-(N-phenyl-2-(N-phenylacetamido)acetamido)acetate
3a (128 mg 72%) as a pale yellow oil, IR: 1751 (C=O), 1682 (C=O),
1658 (C=O) cm−1; 1H NMR (CDCl3): δ 1.24 (t, J = 7.2 Hz, 3H,
CH2CH3), 1.89 (s, 3H, CH3C=O), 4.15 (s, 2H, AcNCH2), 4.17 (q,
J = 7.2 Hz, 2H, CH2CH3), 4.39 (s, 2H, CH2COO), 7.28–7.44 (m, 10H,
ArH); 13C NMR (CDCl3) δ 14.1, 22.1, 51.5, 51.8, 61.3, 127.9, 128.0,
128.3, 128.7, 129.5, 129.9, 141.7, 143.8, 168.4, 168.9, 170.7; HRMS-
ESI (positive) calcd for C20H22N2NaO4+ [M + Na]+: 377.1472; found:
377.1470.
Ethyl 2-(2-(N-phenylacetamido)-N-(p-toyl)acetamido)acetate (3b):
Yellow oil (71%), IR: 1748 (C=O), 1667 (C=O) cm−1; 1H NMR
(CDCl3): δ 1.19 (t, J = 7.2 Hz, 3H, CH2CH3), 1.84 (s, 3H, ArCH3), 2.31
(s, 3H, CH3C=O), 4.11 (q, J = 7.2 Hz, 2H, CH2CH3), 4.12 (s, 2H,
AcNCH2), 4.32 (s, 2H, CH2COO), 7.15 (d, J = 8.2 Hz, 2 H, ArH), 7.25
(d, J = 8.2 Hz, 2H, ArH), 7.27–7.29 (m, 1H, ArH), 7.29–7.35 (m, 4H,
ArH); 13C NMR(CDCl3): δ 14.1, 21.1, 22.1, 51.5, 51.8, 61.1, 127.861,
127.936, 127.947, 129.5, 130.5, 138.6, 139.0, 143.8, 168.5, 168.9,
170.6; HRMS-ESI (positive) calcd for C21H24N2NaO4+ [M + Na]+:
391.1628; found: 391.1624; Eluent: PE/acetone (2/1, v/v), Rf = 0.30.
Ethyl 2-(N-(4-methoxyphenyl)-2-(N-phenylacetamido)acetamido)-
acetate (3c): Light brown oil (67%), IR: 1746 (C=O), 1679 (C=O)
cm−1: 1H NMR (CDCl3): δ 1.18 (t, J = 7.2 Hz, 3H, CH2CH3), 1.82 (s,
3H, CH3C=O), 3.73 (s, 3H, OCH3), 4.09 (s, 2H, AcNCH2), 4.10 (q,
J = 7.2 Hz, 2H, CH2CH3), 4.29 (s, 2H, CH2COO), 6.83 (d, J = 9.2 Hz,
2H, ArH), 7.22–7.31 (m, 7H, ArH); 13C NMR (CDCl3): δ 14.1, 22.1,
51.5, 51.7, 55.4, 61.1, 114.9, 127.8, 127.9, 129.3, 129.5, 134.2, 143.7,
159.5, 168.7, 168.9, 170.6; HRMS-ESI (positive) calcd for
C21H24N2NaO5+ [M + Na]+: 407.1577; found: 407.1580; Eluent: PE/
acetone (2/1, v/v), Rf = 0.26.
acetate (3g): Light yellow oil (73%), IR: 1749 (C=O), 1689 (C=O)
1
cm−1; H NMR (CDCl3): δ 1.19 (t, J = 7.2 Hz, 3H, CH2CH3), 1.83
(t, 3H, CH3C=O), 4.11 (s, 2H, AcNCH2), 4.12 (q, J = 7.2 Hz, 2H,
CH2CH3), 4.30 (s, 2H, CH2COO), 7.23–7.34 (m, 8H, ArH), 7.40 (s,
1H, ArH); 13C NMR (CDCl3): δ 14.1, 22.0, 30.9, 51.3, 51.7, 61.3,
126.7, 127.9, 128.0, 128.5, 129.0, 129.5, 130.9, 135.2, 142.8, 143.6,
168.2, 168.6, 170.6; HRMS-ESI (positive) calcd for C20H21ClN2NaO4+
[M + Na]+: 411.1082; found: 411.1083; Eluent: PE/acetone (2/1, v/v),
Rf = 0.40.
Ethyl 2-(N-(4-fluorophenyl)-2-(N-phenylacetamido)acetamido)-
acetate (3h): Pale yellow oil (71%), IR: 1747 (C=O), 1667 (C=O)
cm−1; 1H NMR (CDCl3): δ 1.18 (t, J = 7.2 Hz, 3H, CH2CH3), 1.82 (s,
3H, CH3C=O), 4.07 (s, 2H, AcNCH2), 4.11 (q, J = 7.2 Hz, 2H,
CH2CH3), 4.30 (s, 2H, CH2COO), 6.99–7.05 (m, 2H, ArH), 7.23–7.28
(m, 1H, ArH), 7.28–7.34 (m, 4H, ArH), 7.36–7.40 (m, 2H, ArH): 13
C
NMR (CDCl3): δ 14.1, 22.0, 51.4, 51.7, 61.2, 116.7 (d, JF-C = 22.5 Hz),
127.9 (overlap, 2C), 129.5, 130.2 (d. JF-C = 8.7 Hz), 137.6 (d, JF-C
=
3.0 Hz), 143.7, 162.2 (d, JF-C = 247.5 Hz), 168.5, 168.8, 170.6; HRMS-
ESI (positive) calcd for C20H21FN2NaO4+ [M + Na]+: 395.1378; found:
395.1378; Eluent: PE/acetone (2/1, v/v), Rf = 0.39.
Ethyl 2-(N-(4-bromophenyl)-2-(N-phenylacetamido)acetamido)-
acetate (3i): Pale yellow oil (69%), IR: 1748 (C=O), 1665 (C=O) cm−1;
1H NMR (CDCl3): δ 1.18 (t, J = 7.2 Hz, 3 H, CH2CH3), 1.82 (s, 3 H,
CH3CO), 4.08 (s, 2 H, AcNCH2), 4.11 (q, J = 7.2 Hz, 2 H, CH2CH3),
4.31 (s, 2 H, CH2COO), 7.22–7.34 (m, 7 H, ArH), 7.47 (d, J = 8.4 Hz,
2 H, ArH); 13C NMR (CDCl3): δ 14.1, 22.1, 51.3, 51.8, 61.3, 122.6,
127.9, 128.0, 129.5, 130.1, 133.1, 140.7, 143.6, 168.2, 168.7, 170.6;
HRMS-ESI (positive) calcd for C20H21BrN2NaO4+ [M + Na]+:
455.0577; found: 455.0579; Eluent: PE/acetone (2/1, v/v), Rf = 0.37.
Ethyl 2-(N-mesityl-2-(N-phenyacetamido)acetamido)acetate (3j):
1
Red-brown oil (19%), IR: 1751 (C=O), 1668 (C=O) cm−1; H NMR
(CDCl3): δ 1.25 (t, J = 7.2 Hz, 3H, CH2CH3), 1.89 (s, 3H, CH3C=O),
2.27 (s, 9H, 3 xArCH3), 4.00 (s, 2H, CH2COO), 4.14 (s, 2H,AcNCH2),
4.19 (q, J = 7.2 Hz, 2H, CH2CH3), 6.91 (s, 2H, ArH), 7.28–7.39
(m, 5H, ArH); 13C NMR (CDCl3): δ 14.1, 18.1, 20.9, 22.2, 51.46,
51.49, 61.1, 127.88, 127.92, 129.5, 130.0, 136.5, 137.0, 138.6, 143.8,
168.4, 168.9, 170.7; HRMS-ESI (positive) calcd for C23H28N2NaO4+
[M + Na]+: 419.1941; found: 419.1944; Eluent: PE/acetone (2/1, v/v),
Rf = 0.33.
Ethyl 2-(N-phenyl-2-(N-phenylbenzamido)acetamido)acetate (3k):
Pale yellow oil (54%), IR: 1749 (C=O), 1682 (C=O), 1651 (C=O)
1
cm−1; H NMR (CDCl3): δ 1.25 (t, J = 7.2 Hz, 3H, CH2CH3), 4.19
Ethyl 2-(N-(3-(methylthio)phenyl)-2-(N-phenylacetamido)acetam-
ido)acetate (3d): Light yellow oil (65%), IR: 1749 (C=O), 1676 (C=O)
cm−1; 1H NMR (CDCl3): δ 1.20 (t, J = 7.2 Hz, 3H, CH2CH3), 1.84 (s,
3H, CH3C=O), 2.42 (s, 3H, SCH3), 4.13 (q, J = 7.2 Hz, 2H, CH2CH3),
4.14 (s, 2H, AcNCH2), 4.31 (s, 2H, CH2COO), 7.12 (d, J = 8.0 Hz, 1H,
ArH), 7.17 (d, J = 8.0 Hz, 1H, ArH), 7.23–7.29 (m, 3H, ArH), 7.29–
7.35 (m, 4H); 13C NMR (CDCl3): δ 14.1, 15.3, 22.1, 51.4, 51.7, 61.3,
124.4, 125.2, 126.1, 127.9, 128.0, 130.0, 130.1, 141.1, 142.2, 143.7,
168.3, 168.8, 170.6; HRMS-ESI (positive) calcd for C21H24N2NaO4S+
[M + Na]+: 423.1349; found: 423.1350; Eluent: PE/acetone (2/1, v/v),
Rf = 0.34.
(q, J = 7.2 Hz, 2H, CH2CH3), 4.42 (s, 2H, CH2COO), 4.44 (s, 2H,
NCH2CON), 7.07–7.23 (m, 8H, ArH), 7.32–7.52 (m, 7H, ArH); 13C
NMR (CDCl3): δ 14.2, 51.5, 52.9, 61.3, 126.6, 127.2, 127.6, 128.3,
128.8, 128.9, 129.0, 129.7, 130.0, 135.4, 141.6, 144.3, 168.5, 169.0,
170.6; HRMS-ESI (positive) calcd for C25H24N2NaO4+ [M + Na]+:
439.1628; found: 439.1630; Eluent: PE/acetone (2/1, v/v), Rf = 0.48.
Ethyl 2-(2-benzamido-N-phenylacetamido)acetate (3l): White
solids (35%), m.p. 128–130 °C, IR: 3433 (NH), 1746 (C=O), 1677
(C=O), 1654 (C=O) cm−1; 1H NMR (CDCl3): δ 1.27 (t, J = 7.2 Hz, 3H,
CH2CH3), 4.02 (d, J = 4.0 Hz, 2H, NCH2CON), 4.21 (q, J = 7.2 Hz,
2H, CH2CH3), 4.40 (s, 2H, CH2COO), 7.24 (t, J = 4.0 Hz, 1 H, NH),
7.37–7.48 (m, 8H, ArH), 7.79 (d, J = 7.2 Hz, 2H, ArH); 13C NMR
Ethyl 2-(N-(4-chlorophenyl)-2-(N-phenylacetamido)acetamido)-
acetate (3e): Pale yellow oil (70%), IR: 1747 (C=O), 1685 (C=O)